Table III.
Characteristic | Overall Survival (OS) from presentation | Progression Free Survival (PFS) from presentation | ||
---|---|---|---|---|
HR (95% CI) | P Value | HR (95% CI) | P Value | |
Patches | 0.09 (0.01–0.75) | .03 | 0.08 (0.01–0.69) | .02 |
Plaques | 4.08 (0.66–25.25) | .13 | 1.51 (0.36–6.36) | .58 |
Hypopigmented lesions | 0.13 (0.01–1.20) | .07 | 0.10 (0.02–0.63) | .014 |
T stage | ||||
T1 | 1.0 | -- | 1.0 | -- |
T2 | 3.04 (0.49–18.87) | .23 | 0.53 (0.11–2.43) | .41 |
N stage | ||||
N0 | 1.0 | -- | 1.0 | -- |
N1/2 | 3.96 (0.95–16.49) | .06 | 0.96 (0.17–5.49) | .97 |
Nx | 28.47 (2.29–354.19) | .009 | 61.35 (5.50–648.38) | .001 |
Elevated WBC | 37.80 (1.65–868.41) | .02 | 4.57 (0.19–111.56) | .35 |
Elevated LDH | 7.80 (1.39–43.84) | .02 | 7.80 (1.39–43.84) | .02 |
Adjusted for sex, insurance type, income, age at diagnosis, and diagnostic delay
Abbreviations: WBC, white blood count; LDH, lactate dehydrogenase